Showing results (71-80 of 90) with videos related to
Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1986
Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experienceD O Dixon, B Neilan, S E Jones, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1987
Stage III follicular lymphoma: durable remissions with a combined chemotherapy-radiotherapy regimenP McLaughlin, L M Fuller, W S Velasquez, et al.International Journal of Radiation Biology|January 1, 1989
Direct estimation of latent time for radiation injury in late-responding normal tissues: gut, lung, and spinal cordS M Bentzen, H D Thames, E L Travis, et al.Investigational New Drugs|December 1, 1987
Arabinosyl-5-azacytosine: a novel nucleoside entering clinical trialsJ L Grem, D D Shoemaker, D F Hoth, et al.Blood|November 1, 1990
Autologous bone marrow transplantation in multiple myeloma: identification of prognostic factorsS Jagannath, B Barlogie, K Dicke, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 1992
Therapy of relapsed or refractory low-grade follicular lymphomas: factors associated with complete remission, survival and time to treatment failureJ A Spinolo, F Cabanillas, D O Dixon, et al.The Pediatric Infectious Disease Journal|December 12, 2001
Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected childrenJ C King, P E Fast, K M Zangwill, et al.Annals of Internal Medicine|August 15, 1996
Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation GroupB S Graham, M C Keefer, M J McElrath, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1986
Improved survival duration with combination chemotherapy induction for multiple myeloma: a Southwest Oncology Group StudyB G Durie, D O Dixon, S Carter, et al.The Journal of Infectious Diseases|February 11, 2000
Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adultsJ C King, J Treanor, P E Fast, et al.Pageof 9